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Abstract A portion of glucokinase appeared to be co-localized 
with actin filaments in the cytoplasm of cultured rat hepatocytes 
incubated with 25 mM glucose. When liver- or islet-type 
glucokinase was transiently expressed in COS-7 cells, the 
expressed glucokinase was also co-localized with actin filaments 
in the cytoplasm of these transfected cells. Although co-
localization of glucokinase with actin filaments was not clearly 
demonstrated in the pancreatic P-cell line MIN6, islet glucoki-
nase was found to be present in both the nucleus and the 
cytoplasm, though predominantly in the nucleus. These findings 
suggest that subcellular localization of glucokinase, including co-
localization with actin filaments, may have an important 
physiological role in metabolic regulation. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Glucokinase (ATP: D-hexose 6-phosphotransferase, EC 
2.7.1.1) plays a key role in the regulation of glucose homeo-
stasis by catalyzing the first step in glycolysis [1]. Expression 
of this enzyme is limited to hepatocytes, pancreatic (3-cells, 
and some neuroendocrine cells [2]. Furthermore, the regula-
tion of glucokinase differs among these tissues. 
We previously reported that liver glucokinase was translo-
cated from the nucleus to the cytoplasm in response to a high 
concentration of glucose [3]. In addition, studies on digitonin-
permeabilized rat hepatocytes demonstrated that, in cells 
equilibrated with 5 m M glucose as the sole carbohydrate sub-
strate, glucokinase was present predominantly in a bound 
state involving a Mg 2 + -dependent mechanism and that some 
substrates, particularly sorbitol and fructose, cause transloca-
tion of glucokinase from the Mg 2 + -dependent binding site 
[4,5]. With respect to glucokinase localization in pancreatic 
|3-cells, a recent study showed that glucokinase has a perinu-
clear cap-like distribution in normal rats and a diffuse distri-
bution throughout the cytoplasm in acutely hyperglycemic 
rats [6]. These results suggest that the subcellular distribution 
of glucokinase plays an important role in glucose metabolism. 
The present study was designed to immunohistochemically 
define the subcellular distributions of liver and islet glucoki-
nase. We first observed that the immunofluorescent staining of 
the enzyme had a mesh-like appearance in the cytoplasm of 
cultured rat hepatocytes incubated with 25 m M glucose for 30 
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min. This observation led us to investigate the possibility that 
glucokinase is co-localized with cytoskeletal elements in rat 
hepatocytes. Herein, we present evidence that glucokinase is 
co-localized with actin filaments in rat hepatocytes and COS-7 
cell transfectants expressing liver- or islet-type glucokinase. 
We further examined the subcellular distribution of endoge-
nous glucokinase in the murine insulinoma cell line M I N 6 . 
2. Materials and methods 
2.1. Cell culture 
COS-7 cells were maintained in Dulbecco's modified Eagle's me-
dium (DMEM; Sigma, USA) containing 5 mM glucose and supple-
mented with 10% heat-inactivated fetal bovine serum (FBS) in hu-
midified 5% C0 2 , 95% air at 37°C. 
Hepatocytes were isolated by collagenase perfusion of livers from 
male Wistar rats fed standard rat chow ad libitum according to the 
method of Tanaka et al. [7]. The rat hepatocytes were suspended in 
Minimum Essential Medium (MEM; GIBCO BRL, USA) supple-
mented with 5 mM glucose and 10% heat-inactivated FBS, and plated 
onto 12-mm round coverslips in 50-mm plastic Petri dishes. The hep-
atocytes were maintained in MEM containing 5 mM glucose and 
supplemented with 10% heat-inactivated FBS in humidified 5% 
CO2, 95% air at 37°C. Unattached cells were removed, after 4 h, by 
replacing serum-free MEM containing 10 nM dexamethasone. The 
culture was then continued for a further 12 h. Histochemical analysis 
was performed after incubation of hepatocytes with 25 mM glucose at 
37°C for 30 min. 
Pancreatic (3-cell line MIN6 cells [8] were maintained in DMEM 
containing 25 mM glucose and supplemented with 15% heat-inacti-
vated FBS in humidified 5% COs, 95% air at 37°C. 
2.2. Overexpression of liver and islet glucokinase in COS-7 cells 
Rat liver glucokinase cDNA [9] or rat islet glucokinase cDNA 
[10,11] was subcloned under the chicken P-actin promoter of the ex-
pression vector pCXN [12]. The resulting expression vector was trans-
fected into COS-7 cells using Lipofectamine (GIBCO BRL, USA) 
following the manufacturer's instructions. The pCXN vector alone 
was transfected into COS-7 cells in parallel experiments to prepare 
the control cells. The cells were fixed for histochemical analysis 42 h 
after transfection. 
2.3. Assay of glucokinase and hexokinase activities in COS-7 cell 
transfectants 
Enzyme activities were assayed fluorometrically by a modification 
of the method of Trus et al. [13]. COS-7 cell transfectants were har-
vested with trypsin-EDTA, washed twice with phosphate-buffered 
saline (PBS) to remove glucose, and homogenized with seven strokes 
in a homogenizing buffer (20 mM K 2HP0 4 , 110 mM KCl, 1 mM 
MgCl2, 1 mM EDTA, and 1 mM dithiothreitol, pH 7.4) using a 
Potter-Elvehjem glass-Teflon homogenizer. The glucose phosphoryl-
ating activity of the total cell homogenate was measured. An aliquot 
of the homogenate was removed to determine protein concentrations. 
The enzyme assays were performed using reaction mixtures (300 ul) 
containing 50 mM Hepes-NaOH buffer (pH 7.6), 100 mM KCl, 8 mM 
MgCl2, 0.5 mM NAD, 5 mM ATP, 1 mM dithiothreitol, 0.5 mg/ml 
bovine serum albumin (BSA), 1 U/ml glucose-6-phosphate dehydro-
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genase from Leuconostoc mesenteroides, 0.5 or 100 mM glucose, and 
sample solution. The reaction mixture was incubated at 37°C for 90 
min. The reaction was then stopped by addition of 150 ul of 500 mM 
sodium phosphate buffer (pH 8.0) containing 0.9 mM sodium dode-
cylsulfate. The hexokinase activity was measured at a glucose concen-
tration of 0.5 mM. The glucokinase activity was estimated by sub-
tracting the activity observed at 0.5 mM glucose from that observed at 
100 mM glucose. The protein concentration was determined by the 
Bradford method with a kit from Bio-Rad (Richmond, CA), using 
BSA as a standard. 
2.4. Histochemical analysis 
For analysis of subcellular distributions of glucokinase and actin, 
the cells were grown on 12-mm round coverslips in 50-mm plastic 
Petri dishes to approximately 80% confluence, washed once with 
PBS, fixed in PBS containing 4% paraformaldehyde for 15 min, and 
permeabilized with PBS containing 0.2% Triton X-100 for 15 min. 
The cells were washed once with PBS containing 0.2% gelatin and 
incubated with affinity-purified anti-glucokinase IgG [3] at 1:100 di-
lution in PBS containing 0.2% gelatin for 1 h at room temperature for 
the transfected COS-7 cells, or overnight at 4°C for cultured hepato-
cytes and MIN6 cells. After three washings with PBS containing 0.2% 
gelatin, the cells were incubated with a mixture of FITC-conjugated 
swine anti-rabbit IgG (DAKO, Denmark) at 1:100 dilution in PBS 
containing 0.2% gelatin and 0.5 |xg/ml TRITC-labeled phalloidin (Sig-
ma, USA) in PBS containing 0.2% gelatin for 1 h at room temper-
ature, washed 3 times with PBS containing 0.2% gelatin, mounted in 
l,4-diazobicyclo-2,2,2-octane/glycerol/PBS, and examined by fluores-
cence microscopy. Appropriate filters were used to obtain two-color 
fluorescence with FITC and TRITC in the same cell population. 
For analysis of the subcellular glucokinase distribution in MIN6 
cells by the immunoperoxidase staining method, the cells were grown 
on 12-mm round coverslips in 50-mm plastic Petri dishes to approx-
imately 60% confluence, washed once with PBS, fixed in PBS contain-
ing 3% paraformaldehyde for 15 min, permeabilized with PBS con-
taining 0.2%i Triton X-100 for 15 min, washed once with PBS, and 
incubated with PBS containing 0.3%> (w/v) H202 for 30 min to block 
endogenous peroxidase activity. The cells were then washed once with 
PBS, and incubated with normal goat serum for 20 min at room 
temperature, with affinity-purified anti-glucokinase IgG [3] at 1:100 
dilution in 5% normal goat serum overnight at 4°C, with biotin-la-
beled goat serum against rabbit IgG (Seikagaku Kogyo, Japan) for 1 h 
at 20°C, and then with streptavidin-peroxidase (Seikagaku Kogyo, 
Japan) for 1 h at 20°C. Each incubation was followed by three wash-
ings with PBS. The cells were then incubated with 0.05% (w/v) 3,3'-
diaminobenzidine-4HCl and 0.01% (w/v) H2O2 for 15 min at room 
temperature for staining, washed with distilled water, mounted in 
PBS/glycerol, and examined by light microscopy. 
In control experiments for histochemical studies, the cells were 
treated in the same fashion except that the anti-glucokinase IgG 
was replaced by non-immune rabbit IgG, pre-immune rabbit IgG, 
or anti-glucokinase rabbit IgG preabsorbed with rat liver glucokinase. 
The cells were also incubated directly with the second antibody, i.e. 
without a preceding incubation with anti-glucokinase IgG. 
3. Results 
Glucokinase immunofluorescence staining with affinity-pur-
ified anti-glucokinase IgG was present in both the nucleus and 
the cytoplasm of cultured rat hepatocytes incubated with 25 
mM glucose for 30 min (Fig. 1A). It was noteworthy that a 
portion of the glucokinase staining exhibited a mesh-like dis-
tribution in the cytoplasm. The specificity of glucokinase im-
munostaining was demonstrated by the following results: (1) 
no staining was observed when non-immune or pre-immune 
IgG was used instead of anti-glucokinase IgG; (2) immunoab-
sorption of anti-glucokinase IgG with purified rat liver gluco-
kinase completely prevented immunostaining of glucokinase; 
(3) no staining was observed when the cells were incubated 
with the second antibody without preceding incubation with 
anti-glucokinase antibody (data not shown). These observa-
tions indicate that the immunostaining is specific for glucoki-
nase. When double labeling of cultured rat hepatocytes using 
anti-glucokinase antibody and TRITC-labeled phalloidin was 
performed, a portion of the glucokinase staining appeared to 
coincide with actin staining in the same area of the cytoplasm 
(Fig. 1A.B). 
Glucose phosphorylating activities in COS-7 cells express-
ing liver- or islet-type glucokinase are shown in Table 1. The 
DNA constructs for the expressions of liver- and islet-type 
glucokinase were transiently transfected into COS-7 cells. 
The total homogenates of cells transfected with the pCXN 
vector alone (control) possessed only high-affinity glucose 
phosphorylating activity, consistent with that of hexokinase. 
The total homogenates of cells transfected with the pCXN 
vector containing either liver or islet glucokinase cDNA ex-
hibited not only high-affinity but also low-affinity glucose 
phosphorylating activities, indicating that glucokinase was in-
deed expressed in the transfectants. 
COS-7 cell transfectants expressing liver- or islet-type glu-
cokinase were examined by double staining using anti-gluco-
kinase antibody and TRITC-labeled phalloidin. The control 
cells transfected with pCXN alone did not exhibit glucokinase 
staining (data not shown). Abundant glucokinase staining was 
recognized in both the nucleus and the cytoplasm of the trans-
Fig. 1. Double fluorescent labeling of cultured rat hepatocytes with anti-glucokinase antibody and TRITC-labeled phalloidin. The same popula-
tion of cultured rat hepatocytes was double stained with anti-glucokinase antibody (A) and TRITC-labeled phalloidin (B). Bar= 10 urn. 
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Fig. 2. Double fluorescent labeling of COS-7 cells expressing either liver- or islet-type glucokinase using anti-glucokinase antibody and TRITC-
labeled phalloidin. COS-7 cells were transfected with expression vector pCXN containing the cDNA encoding rat liver glucokinase or rat islet 
glucokinase. The same population of liver-type glucokinase expressing COS-7 cells was double stained with anti-glucokinase antibody (A) and 
TRITC-labeled phalloidin (B). The same population of islet-type glucokinase expressing COS-7 cells was double stained with anti-glucokinase 
antibody (C) and TRITC-labeled phalloidin (D). Bar=20 urn. 
fectants expressing liver-type glucokinase (Fig. 2A) and islet-
type glucokinase (Fig. 2C). In the same area of the cytoplasm 
in transfected cells, the staining of the expressed glucokinase 
was co-localized with that of actin filaments (Fig. 2A-D), with 
a subcellular distribution similar to that of endogenous glu-
cokinase in cultured rat hepatocytes (Fig. 1A,B). 
We then attempted to examine the subcellular distribution 
of glucokinase, especially the apparent co-localization with 
actin filaments, in the pancreatic p-cell line MIN6 by double 
staining using anti-glucokinase antibody and TRITC-labeled 
phalloidin. However, we were unable to obtain clear results 
reflecting the subcellular distribution of glucokinase. This was 
due mainly to the low sensitivity for glucokinase staining as 
the amount of glucokinase is relatively low in MIN6 cells 
compared with cultured rat hepatocytes and COS-7 cell trans-
fectants. To increase this sensitivity and thereby enhance de-
tection, we employed an immunoperoxidase staining method, 
demonstrating that glucokinase immunoreactivity was present 
in both the nucleus and the cytoplasm of MIN6 cells (Fig. 3), 
and that the signal was far stronger in the nucleus than in the 
cytoplasm. These signals were not observed when MIN6 cells 
were first incubated with non-immune rabbit IgG, pre-im-
mune rabbit IgG, or anti-glucokinase rabbit IgG preincubated 
with rat liver glucokinase (data not shown). 
4. Discussion 
Fig. 3. Immunohistochemical distribution of glucokinase in the pan-
creatic pi-cell line MIN6. The brown color indicates positive staining 
for glucokinase. Bar= 10 urn. 
Several glycolytic enzymes have been demonstrated to be 
associated with cytoskeletal elements such as actin and tubu-
lin, and the activities of these enzymes differ between bound 
and soluble states [14]. It has therefore been proposed that the 
associations of some glycolytic enzymes with the cytoskeleton 
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Table 1 
Glucokmase and hexokinase activities in homogenates of COS-7 cells expressing liver- or islet-type glucokinase 
Expression vector Glucokinase Hexokinase 
(nmol/min/mg protein) (nmol/min/mg protein) 
pCXN (control not detected 18.3 ± 1.2 
pCXN-liver glucokinase 4.7 ±0.8 21.5 ±2.7 
pCXN-islet glucokinase 4.2 ± 1.1 20.3 ± 2.6 
The expression vector pCXN containing liver glucokmase cDNA (pCXN-liver glucokmase) or islet glucokinase cDNA (pCXN-islet gluckinase) was 
transiently transfected into COS-7 cells. The pCXN vector alone was transfected into COS-7 cells in parallel experiments to prepare the control 
cells. Glucose phosphorylating activities in transfectant homogenates were determined 42 h after transfection. Glucokinase and hexokinase activities 
were determined as described in Section 2. 
Data are means ± SEM of three experiments. 
have functional significance, perhaps involving a localized 
source of glycolytically derived energy for energy-dependent 
and cytoskeletal affiliated intracellular functions [14]. In the 
present study, we demonstrated that a portion of endogenous 
liver glucokinase is co-localized with actin filaments in the 
cytoplasm of cultured rat hepatocytes incubated with 25 
mM glucose for 30 min. In addition, exogenous liver-type 
glucokinase expressed in COS-7 cells also showed partial co-
localization with actin filaments in the cytoplasm. These re-
sults suggest that the co-localization of liver glucokinase with 
actin filaments has functional significance; the metabolic con-
trol which occurs via glucokinase may be due, at least in part, 
to the physical association of glucokinase with actin filaments 
in hepatocytes. 
It has been reported that cytochalasin D and phalloidin, 
which interfere with microfilament structure, increase glucoki-
nase release during permeabilization of cultured rat hepato-
cytes with digitonin [4]. Although these results suggest that 
changes in microfilament conformation affect glucokinase 
binding, no morphological evidence was provided [4]. In the 
present study, co-localization of glucokinase with actin fila-
ments was directly demonstrated in cultured hepatocytes em-
ploying a histochemical technique. Taken together with our 
results, the previous observation of increased glucokinase re-
lease by cytochalasin D and phalloidin may be attributable 
to disruption of the association between glucokinase and actin 
filaments. 
Another interesting observation is that cultured hepato-
cytes, COS-7 cells expressing liver- or islet-type glucokinase, 
and MIN6 cells exhibited strong nuclear glucokinase staining. 
It is not clear whether this nuclear staining indicates an asso-
ciation of the enzyme with the nuclear membrane or local-
ization within the nucleus, because glucokinase immunoreac-
tivity was not analyzed in thin sections or with confocal laser 
scanning microscopy in these cells. However, considering that 
liver glucokinase has been identified as a nuclear protein by 
immunohistochemical studies using paraffin-embedded sec-
tions prepared from rat liver [3,15], it is more likely that the 
nuclear stainings observed in cultured hepatocytes and COS-7 
cells expressing liver-type glucokinase come from glucokinase 
localized within the nucleus. 
We previously reported that in situ perfusion of the liver 
with 20 mM glucose for 10 min caused a marked decrease in 
nuclear immunoreactivity and an increase in cytoplasmic im-
munoreactivity, and that insulin (10 nmol/1) potentiated this 
glucose effect [3]. Similarly, incubation of cultured rat hepa-
tocytes with high concentrations of glucose (10-40 mM) for 
30 min induced translocation of glucokinase from the nucleus 
to the cytoplasm [16]. Therefore, it has been hypothesized that 
the localization of glucokinase in nuclei minimizes the futile 
substrate cycle between glucose and glucose 6-phosphate (G/ 
G-6-P cycle) and that translocation of glucokinase between 
the nucleus and the cytoplasm may operate as a means of 
regulating glucose metabolism. In the present study, incuba-
tion of COS-7 cells expressing liver-type glucokinase with dif-
ferent concentrations of glucose (5, 10 and 20 mM) for 30 min 
produced no apparent translocation of glucokinase from the 
nucleus to the cytoplasm in response to an increase in the 
glucose concentration (data not shown). Therefore, glucoki-
nase translocation may be unique to the liver, and may have 
functional significance in hepatic glucose metabolism. 
As to the mechanism governing the specific subcellular lo-
calization of glucokinase, it is noteworthy that liver-type and 
islet-type glucokinases have been shown to exert essentially 
the same stimulatory effect on glucose metabolism when over-
expressed in primary cultured rat hepatocytes [17]. This ob-
servation suggests a possibility that these expressed glucoki-
nases are localized to the same compartment in primary 
cultured rat hepatocytes, and thus that the amino-terminal 
domain of glucokinase, which differs between the liver-type 
and islet-type, is not involved in the specific subcellular target-
ing of glucokinase. Further studies are needed to clarify 
the mechanism governing the specific localization of glucokin-
ase. 
Glucose-induced translocation of glucokinase has also been 
reported in rat pancreatic P-cells [6], although the subcellular 
localization is somewhat different from our observation in 
MIN6 cells. We were unable to obtain clear immunofluores-
cent staining data to identify whether the endogenous islet 
glucokinase is associated with cytoskeletal elements in the 
pancreatic P-cell line MIN6 because of the weak signal. How-
ever, the exogenous islet-type glucokinase was co-localized 
with actin filaments in COS-7 cells expressing islet-type glu-
cokinase, suggesting the possibility that endogenous islet glu-
cokinase is co-localized with actin filaments in pancreatic p-
cells as well. Overexpression of glucokinase in isolated islets 
reportedly has minimal effects on glucose metabolism and 
insulin release [18], suggesting that the number of putative 
glucokinase binding sites which upon activation engage in 
metabolic signaling is limited in islet cells. Our observations 
suggest that a glucokinase binding site in pancreatic P-cells 
resides in the nucleus and/or on actin filaments. The possible 
co-localization with cytoskeletal elements and location-de-
pendent enhancement of glucokinase activity in the glucose-
sensing machinery of P-cells merit further investigation. 
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